Skip to content

Model 438-01 Cardifix Implantable Pacing Lead

by Intermedics, Inc. 510(k)

Active United States

510(k) K862052

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK862052 Date3 Jul 1986ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Model 438-01 Cardifix Implantable Pacing Lead is a permanent pacemaker electrode designed for transvenous implantation. It delivers electrical stimulation to the heart to regulate cardiac rhythm in patients with bradycardia or conduction disorders, ensuring consistent pacing via its fixed electrode configuration.

This lead is intended for surgical implantation by a healthcare professional in a sterile operating environment. Supplied sterile and single-use, it adheres to FDA 510(k) clearance under the traditional review pathway, classified as a Class III device (K862052). Compliance with regulation 870.3680 ensures adherence to cardiovascular implant standards, with no reusable components or MRI compatibility specified in the data.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Model 438-01 Cardifix Implantable Pacing Lead, and how is it used in clinical practice?

    The Model 438-01 Cardifix Implantable Pacing Lead is designed to deliver electrical stimulation to the heart for patients with bradycardia or conduction disorders, ensuring consistent pacing via its fixed electrode configuration. It is intended for transvenous implantation—meaning it is inserted through a vein—by a healthcare professional in a sterile operating environment. This lead helps regulate cardiac rhythm by providing reliable pacing support.

  • Is the Model 438-01 Cardifix Implantable Pacing Lead reusable, or is it meant for single-use only?

    The Model 438-01 Cardifix Implantable Pacing Lead is supplied sterile and intended for single-use only. It is not designed for reuse, as this could compromise sterility and patient safety. Each lead is meant to be implanted once in a controlled surgical setting.

  • What regulatory pathway was followed for FDA clearance of this device, and what classification does it hold?

    The Model 438-01 Cardifix Implantable Pacing Lead was cleared under the traditional review pathway by the FDA via a 510(k) submission (K862052). It is classified as a Class III device, which is the highest regulatory classification for medical devices requiring strict oversight due to its role in life-sustaining or life-supporting functions, such as cardiac pacing.

  • What compliance standards does this device adhere to, particularly regarding cardiovascular implant requirements?

    The Model 438-01 adheres to FDA regulation 870.3680, which establishes compliance standards for cardiovascular implant devices. This regulation ensures that the lead meets specific performance, safety, and labeling requirements for transvenous pacing leads, including design, testing, and manufacturing controls.

  • How should the Model 438-01 Cardifix Implantable Pacing Lead be stored before use, given its sterile packaging?

    Since the Model 438-01 is supplied sterile and single-use, it should be stored in its original, unopened packaging in a clean, dry environment away from direct sunlight or extreme temperatures. The packaging should remain intact until immediately before use to maintain sterility, as opening or exposing it prematurely could compromise its sterile condition.